SCHEMBL6207591

SCHEMBL6207591

CC(C)(C)OC(=O)NCCC[C@H](O)c1ncco1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
GAA P10253 1/20 0.51
STK17B O94768 1/20 0.45
STK17A Q9UEE5 1/20 0.45
CA12 O43570 5/20 0.44
CA1 P00915 5/20 0.44
CA2 P00918 5/20 0.44
CA9 Q16790 5/20 0.44
TDP1 Q9NUW8 4/20 0.43
CYP1A1 P04798 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP3A43 Q9HB55 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23314817 0.86 PCSK9 (0.41) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL25496776 0.76 MEN1 (0.56) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL10178236 0.76 HTT (0.54) MEN1KMT2AGAACA12CA1
SCHEMBL5489553 0.75 MEN1 (0.43) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL6206669 0.75 MEN1 (0.43) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL25496745 0.74 CYP3A4 (0.56) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL29907305 0.74 CYP3A4 (0.56) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL28975900 0.74 CYP3A4 (0.56) MEN1KMT2AGAASTK17BSTK17A
SCHEMBL5693653 0.74 S1PR1 (0.51) MEN1KMT2AGAATDP1MAPT
SCHEMBL6206334 0.73 MEN1 (0.46) MEN1KMT2AGAASTK17BSTK17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515726-A1 MORPHOLINE AND TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2005-03-23 EP disclosed
WO-2004002491-A1 MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2004-01-08 WO disclosed